Alwis Group is proud to be a Gold Sponsor at the upcoming WHY Summit – Future of Pharmacovigilance World Tour / World Drug Safety Summit in Basel, Switzerland. This global event will bring together leading experts and innovators to discuss the evolving landscape of drug safety and pharmacovigilance, aligning with [...]
ALWIS Group proudly participated in this high-impact summit focused on advancing drug safety through innovation and collaboration. The two-day event brought together global pharmacovigilance leaders, regulatory experts, and tech pioneers to discuss the evolving landscape of safety monitoring. At the heart of our presence was ReTrans Enterprise, our flagship AI-powered [...]
At the Global Drug Safety & PV Outsourcing Summit 2024 held in Mumbai, ALWIS Group participated as a Silver Sponsor, highlighting its commitment to advancing pharmacovigilance through innovative AI-driven solutions. While specific details of their presentation are not publicly available, ALWIS Group’s showcased products included: [...]
We’re proud to announce that a Fortune 500 pharmaceutical leader has officially gone live with ReTrans, our AI-driven literature surveillance platform. This milestone not only reinforces the growing global trust in ALWIS Group’s technological innovations but also showcases the scalability, compliance, and efficiency of ReTrans in enterprise pharmacovigilance environments. As [...]